Streptococcus pyogenes,(colloquially named “group A streptococcus”(GAS)), is a pathogen
of public health significance, infecting 18.1 million people worldwide and resulting in …

Group A Streptococcus (GAS) causes superficial and invasive infections and immune
mediated post-infectious sequalae (including acute rheumatic fever/rheumatic heart …

Summary Background Group A streptococcal (GAS) infections can trigger an immune-
mediated response resulting in acute rheumatic fever (ARF). The role of social and …

Considering the lack of existing evidence on economic burden for diseases caused by
group A Streptococcus, we estimated the economic burden per episode for selected …

Background Acute rheumatic fever (ARF) is a serious post-infectious sequala of Group A
Streptococcus (GAS, Streptococcus pyogenes). In New Zealand (NZ) ARF is a major cause …

Background There is a dearth of evidence on the cost-effectiveness of a combination of
population-based primary, secondary, and tertiary prevention and control strategies for …

During the 1920s, acute rheumatic fever (ARF) was the leading cause of mortality in children
in the United States. By the 1980s, many felt ARF had all but disappeared from the US …

Abstract Background Group A Streptococcus (GAS) causes superficial pharyngitis and skin
infections as well as serious autoimmune sequelae such as acute rheumatic fever (ARF) …

Infections with Streptococcus pyogenes and their sequelae are responsible for an estimated
18 million cases of serious disease with> 700 million new primary cases and 500,000 …

Background Acute rheumatic fever (ARF) is a serious sequela of Group A Streptococcus
(GAS) infection associated with significant global mortality. Pathogenesis remains poorly …